A limited revision-fee program can support planning without promising a result
If a revision policy is part of how you are comparing breast augmentation surgeons in Beverly Hills, it is reasonable to ask what it actually covers—and what it does not. A limited program may offer useful reassurance about one narrow part of the financial discussion. It should not replace careful surgical planning or be treated as a promise of a particular appearance.
Confirm the current written terms directly with the practice before relying on the program.
Most importantly, a revision-fee program is not an outcome guarantee. Breast augmentation involves decisions about implant characteristics, placement, anatomy, recovery, and realistic expectations. Results vary, and a policy does not mean that a particular size, shape, symmetry, sensation, or recovery experience can be assured.
It is also different from a manufacturer warranty, which concerns the implant device under its own terms, and from insurance coverage. The FDA notes that insurance may not cover implant removal or replacement, even when complications occur. Breast implants are not lifetime devices, and the FDA advises prospective patients to assume that additional operations may be needed over time. Those broader long-term considerations remain relevant even when a practice offers a short-term revision-fee policy.
The practical question is not whether a policy makes surgery consequence-free. It is whether the current written terms provide meaningful, limited reassurance for your exact planned primary breast augmentation at the Beverly Hills office. That requires two conversations: one about whether the surgical plan suits you, and another about whether the stated program applies.
Why breast revision belongs in an informed implant discussion
A breast revision, also called revision mammaplasty, is surgery that may address unsatisfactory results after a prior breast augmentation or breast lift. Raising the subject before primary surgery is not a prediction that you will need another operation. It is part of understanding that implants require ongoing attention and that future changes, concerns, or complications may lead to another decision.
Depending on the situation, revision surgery may involve changing implant size or position, treating scar tissue, using internal suturing, performing a breast lift, or selecting a different implant style. These are possible surgical approaches, not a menu of preapproved solutions. The appropriate response to a concern depends on a clinician’s evaluation of the individual situation.
Revision discussions may arise for aesthetic or clinical reasons. Examples cited in breast revision information include capsular contracture, implant-position changes, rupture or deflation, discomfort, asymmetry, implant visibility or rippling, and an unanticipated breast shape. The FDA lists capsular contracture, reoperation, and implant removal among common local complications or adverse outcomes. Its materials also list risks including rupture or deflation, wrinkling, asymmetry, scarring, pain, and infection.
That context helps put a 90-day policy in perspective. A stated short-term program does not establish coverage for every future concern, and it does not change the fact that implants are not lifetime devices. Rather than viewing revision as evidence that a primary procedure has necessarily failed, treat it as one of the subjects that belongs in informed planning.
A productive consultation makes room for both hopes and limits. You can explain the proportions and degree of fullness you prefer, ask what may be realistic for your anatomy, and discuss what outcomes would concern you during recovery. You can also ask how the practice distinguishes normal healing from an issue that merits evaluation. That discussion is educational and individualized; it cannot predict a specific result or determine in advance whether a revision would be appropriate.
The stated coverage boundary for the Beverly Hills program
The program has a defined boundary rather than open-ended protection. Read the following as the stated scope to confirm in writing with Golshani Plastic Surgery for your planned procedure:
- Procedure: The program is stated to be limited to a primary breast augmentation case.
- Location: The primary procedure is stated to need to be performed at the Beverly Hills office.
- Timeframe: The summary states a 90-day period beginning on the original surgery date.
- Number of revisions: It states that there may be one revision under the program.
- Fee described: The program is stated to waive the standard surgeon’s fee for the revision procedure.
The phrase “no-cost revision” needs careful reading in context. The supplied summary specifically identifies a waiver of the standard surgeon’s fee. It does not establish that every cost associated with a revision is covered. Nor does it define how dissatisfaction is evaluated, who determines eligibility, whether medical or timing exceptions apply, or whether an in-person assessment is required.
For that reason, a practical way to use the program in your decision is as a question set, not as an assumption. Ask for the current written terms and have the practice confirm that your procedure is a qualifying primary augmentation at the Beverly Hills office. Ask how the 90 days are calculated and what steps are required if you have a concern during that period.
This focused approach is especially helpful when you are weighing an individualized treatment plan. Implant planning may consider chest-wall anatomy, existing breast tissue, skin quality and laxity, and aesthetic goals. A policy boundary cannot determine those choices. It may be relevant once a plan is proposed, but it should not drive a decision toward an implant size, shape, or procedure that does not fit your goals and clinical evaluation.
What the stated terms exclude and do not establish
Procedures performed at another location or by another surgeon are excluded. If you are considering surgery outside the Beverly Hills office, or you are seeking correction of an operation performed elsewhere, do not assume this stated program applies. Request confirmation of the current written terms directly from the practice.
There is a second boundary that matters just as much: the supplied information identifies only the standard surgeon’s fee as waived. It does not establish coverage for facility fees, anesthesia, implants or other devices, medications, imaging, laboratory work, travel, postoperative care, or other non-surgeon costs. It also does not establish whether those items would be needed in a particular circumstance.
That is not a minor administrative detail. A patient deciding whether the program offers relevant reassurance needs to understand the difference between a surgeon-fee waiver and comprehensive financial coverage. The latter should not be inferred from the stated program summary.
Use this checklist when asking for clarification:
- Confirm the exact qualifying procedure. Is my proposed operation classified as a primary breast augmentation under the current policy?
- Confirm the site and surgeon. Will the planned surgery be performed at the Beverly Hills office by the surgeon covered by the policy?
- Confirm the clock. What is the exact start and end date of the 90-day period for my surgery date?
- Confirm the decision process. How are concerns, dissatisfaction, timing, and eligibility assessed under the current written terms?
- Request an itemized cost boundary. Which costs, if any, remain the patient’s responsibility if a revision is considered?
- Ask about the one-revision limit. How is the stated one-revision limit applied if a patient has more than one concern?
A clear answer to these questions lets you compare the program accurately with other considerations, including surgical planning, recovery arrangements, implant-specific information, and your tolerance for the possibility of future procedures. If the terms are not clear enough for you to make an informed choice, pause before treating the program as a deciding benefit.
Use the consultation to confirm both the surgical plan and program fit
A consultation is not a single yes-or-no conversation about a policy. It is a two-track decision: first, whether the proposed breast augmentation plan fits your body and priorities; second, whether the current written program applies to that exact plan.
Track one: Is the proposed primary augmentation plan appropriate to discuss further?
The FDA says a preoperative consultation should cover candidacy, implant choices, placement, and risks and benefits in light of the patient’s circumstances. FDA materials also advise patients to discuss their goals and expectations with their surgeon and to read implant-specific labeling and educational materials before deciding.
At Dr. Golshani’s practice, the breast augmentation page states that implant planning considers chest-wall anatomy, existing breast tissue, skin quality and laxity, and aesthetic goals. This is why a photo, a cup-size preference, or a friend’s result cannot by itself determine the right plan for another person.
Bring questions that help you understand the recommendation:
- What goals can this plan reasonably aim to address, and what should I not expect it to change?
- How do my chest-wall anatomy, existing breast tissue, skin quality, and goals influence implant type, size, shape, and placement?
- What are the meaningful tradeoffs among the options being discussed for me?
- What recovery restrictions, follow-up needs, and uncertainties should I plan around?
- What risks are most relevant to the procedure under consideration, and what changes should prompt me to contact the practice?
- Can I review the manufacturer’s patient labeling and ask questions before making a decision?
For FDA-approved breast implants, FDA materials state that the prospective patient and implanting physician must review and sign the patient decision checklist. Treat that checklist as an opportunity to slow down and ask for plain-language explanations, rather than as paperwork to rush through.
Breast augmentation alone does not correct significant breast sagging, according to Dr. Golshani’s breast augmentation page. In appropriate cases, a breast lift may be combined with augmentation. This does not mean a combined procedure is right for everyone; it means that the consultation should separate the goal of adding volume from the goal of changing breast position.
Track two: Does the current program apply to this exact plan?
After you understand the surgical recommendation, ask the practice to confirm the policy terms for that proposed primary procedure. Keep the questions specific:
- Is this planned operation eligible under the current Revision Assurance Program?
- Does the current written policy apply because the procedure will be performed at the Beverly Hills office?
- What does the practice mean by dissatisfaction or eligibility within the stated 90-day period?
- Does a concern require a clinical evaluation before any revision decision is made?
- Does the policy waive only the standard surgeon’s fee, and what costs are not included?
- Can I receive the current written terms before scheduling surgery?
Ending each track with a clear boundary protects against confusion. If you do not understand the individualized surgical rationale, ask for clarification before deciding. If the policy’s current applicability or costs are not confirmed in writing, do not treat the stated program as confirmed coverage.
Move forward with clarity and confirmed terms
A 90-day revision-fee program may be one consideration when choosing a primary breast augmentation consultation in Beverly Hills. It is not a promise of a specific aesthetic outcome, a substitute for implant-specific informed consent, or a complete answer to future implant-related costs and decisions.
The stronger basis for moving forward is clarity on both sides of the decision. You should understand why a proposed plan reflects your anatomy and goals, what recovery and risks deserve consideration, and what realistic expectations look like. You should also have the current written program terms, including confirmation that the planned procedure qualifies and a clear explanation of any costs outside the stated surgeon-fee waiver.
Educational information cannot determine candidacy, predict outcomes, or decide whether a revision would be appropriate for an individual patient. A consultation with Dr. Golshani in Beverly Hills can address your goals, recovery questions, risks, implant planning, and the current applicability of the stated program to your planned procedure.
Questions to bring to Dr. Golshani about augmentation and the stated program
What does a breast revision usually address after augmentation?
It is surgery used to address concerns after a prior breast augmentation or lift. Depending on the situation, it may involve changing implant size or position, treating scar tissue, internal suturing, a breast lift, or a different implant style.
Does the stated 90-day program cover every revision cost?
No. The program waives the standard surgeon’s fee. It does not establish coverage for facility, anesthesia, implant or device costs, medications, imaging, travel, or postoperative care.
Who is the stated program meant to apply to?
The program is limited to primary breast augmentation cases performed at the Beverly Hills office. It does not apply to procedures done elsewhere or by another surgeon.
What should I confirm during consultation before relying on the program?
Ask whether your planned procedure qualifies, how the 90 days are counted, how dissatisfaction or eligibility is assessed, whether any evaluation is required, and which costs are included or excluded in writing.
Why do implants need long-term follow-up even if a revision policy is offered?
Breast implants are not lifetime devices, and the FDA advises patients to assume additional surgery may be needed over time.
Can breast augmentation address sagging as well as fullness?
If sagging is part of your concern, a breast lift may be discussed with augmentation so volume and position are addressed together when appropriate.

Leave a Reply